Rapid growth: Global sales of
non-cancer gene therapies are expected to grow by almost 20% by 2028
Gene therapies
global sales1) [USD m, '19-'28]
Forecast
341
3
861
3
1,223
3
1
1,251
16
2
1
1,419
244
118
98
96
28
26
9
1
1,535
326
274
210
96
91
41
19
1
1,650
531
308
302
140
94
54
30
1
1,762
719
349
330
203
92
77
38
1
1,858
893
359
249
227
98
91
47
1
1,960
1,067
388
326
281
133
87
56
1
344
864
1,227
1,270
2,039
2,593
3,110
3,571
3,823
4,299
Zolgensma
Roctavian
Luxturna
Hemgenix
Zynteglo
Libmeldy
Imlygic
Skysona
Strimvelis
